Summary
Trust in the U.S. Food and Drug Administration (FDA) has dropped sharply, with only about half of Americans now saying they trust the agency. This is a big fall from roughly 75% just two years ago. The main reason is not about the FDA's ability to do its job, but about worries that politics is interfering with its decisions. Experts say the agency needs to be more open, consistent, and science-based to win back public confidence. This matters because the FDA decides if medicines, vaccines, and food are safe for everyone.
Main Impact
The loss of trust in the FDA affects everyone. Patients may hesitate to take approved medicines or vaccines. Drug companies may be less willing to invest in new treatments if they fear the rules will change suddenly. Investors may pull back from funding medical research. The agency's role is to protect public health, but when people doubt its independence, the whole system of medical innovation and safety is weakened. Restoring trust is not just about one decision—it is about rebuilding the foundation of how the FDA works.
Key Details
What Happened
Recent polls show a steep decline in public trust. A KFF tracking poll found fewer than half of Americans believe the FDA can make decisions without political pressure. A Harvard survey from June 2026 showed most people think federal health recommendations are too influenced by leaders' personal beliefs instead of evidence. These findings come after several controversial FDA decisions that critics say were inconsistent or politically motivated.
Important Numbers and Facts
Trust in the FDA fell from about 75% two years ago to roughly 50% now. The drop is linked to decisions on drugs like Replimune's therapy for melanoma, uniQure's gene therapy for Huntington disease, and Regenxbio's treatment for Hunter syndrome. There was also a sudden change in the review of Moderna's mRNA flu vaccine, which unsettled the entire vaccine industry. The FDA has started to revisit some of these decisions under Acting Commissioner Kyle Diamantas.
Background and Context
The FDA was created to protect people from unsafe or mislabeled products. It reviews drugs, vaccines, medical devices, and food to make sure they are safe and work as promised. For decades, the agency was seen as a gold standard worldwide. But recent events have raised questions about whether it is still following science or giving in to political pressure. The agency also oversees food safety, which is part of its full name: the Food and Drug Administration. Experts say the FDA needs modern tools and more funding to keep up with new technologies like AI diagnostics and digital health tools.
Public or Industry Reaction
Patient groups, doctors, and drug companies have all voiced concern. Rare disease advocates have been especially upset because patients with these conditions often have no other treatment options. The biotech industry worries that unpredictable FDA decisions make it hard to plan long-term research. Some critics say the agency lowered its standards, while others say it became too strict. The FDA's own staff and advisory committees have also expressed frustration. The agency's response has been to start reviewing some of the most controversial decisions, but many say this is just a first step.
What This Means Going Forward
To rebuild trust, the FDA must do more than fix a few past mistakes. It needs to be transparent about how it makes decisions. It should stick to the rules it sets for drug trials and not change them late in the process. It must use outside experts wisely and explain clearly when it changes course. The agency also needs better technology to track the safety of products after they are on the market. The next FDA commissioner should be a scientist or public health expert, not a political figure. Without these changes, the loss of trust could slow down medical progress and put patients at risk.
Final Take
The FDA is at a turning point. It can either become more open and science-driven, or continue to lose the public's faith. The agency was built on the idea that safety and evidence come first. That idea is still the right one, but it needs to be backed up by action. If the FDA can show it is independent and fair, it can regain trust and continue to protect public health for years to come.
Frequently Asked Questions
Why has trust in the FDA dropped so much?
Trust has fallen because many people believe political pressure, not science, is driving the agency's decisions. Recent polls show that fewer than half of Americans think the FDA can act independently. Controversial decisions on certain drugs and vaccines have added to these doubts.
What can the FDA do to regain public trust?
The FDA needs to be more transparent about how it makes decisions. It should apply its rules consistently, explain changes clearly, and rely on scientific evidence. It also needs to modernize its systems and fund its inspection and research staff properly.
Does the loss of trust affect food safety too?
Yes. The FDA is also responsible for food safety, including preventing outbreaks of foodborne illness. If people do not trust the agency, they may question the safety of the food supply. Experts say the FDA needs more inspectors and better data systems to do this job well.
